Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2.
about
PPAR-gamma: Therapeutic Potential for Multiple SclerosisAlzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and GammaProtective Microglia and Their Regulation in Parkinson's DiseaseAstaxanthin ameliorates prenatal LPS-exposed behavioral deficits and oxidative stress in adult offspring.Modulation of microglial innate immunity in Alzheimer's disease by activation of peroxisome proliferator-activated receptor gamma.PPAR-alpha and PPAR-beta expression changes in the hippocampus of rats undergoing global cerebral ischemia/reperfusion due to PPAR-gamma statusProtection of neurons and microglia against ethanol in a mouse model of fetal alcohol spectrum disorders by peroxisome proliferator-activated receptor-γ agonists.Pan-PPAR modulation effectively protects APP/PS1 mice from amyloid deposition and cognitive deficitsThe PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys.Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.Ischemic preconditioning via epsilon protein kinase C activation requires cyclooxygenase-2 activation in vitroPioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/AktRegulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?Serum perfluoroalkyl acids concentrations and memory impairment in a large cross-sectional studyPreconditioning mediated by sublethal oxygen-glucose deprivation-induced cyclooxygenase-2 expression via the signal transducers and activators of transcription 3 phosphorylation.Regulation of Glial Cell Functions by PPAR-gamma Natural and Synthetic Agonists.Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinson's DiseaseRosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists.Fenretinide inhibits macrophage inflammatory mediators and controls hypertension in spontaneously hypertensive rats via the peroxisome proliferator-activated receptor gamma pathway.Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease.Modulating microglia activity with PPAR-γ agonists: a promising therapy for Parkinson's disease?Preclinical to phase II amyloid beta (Aβ) peptide modulators under investigation for Alzheimer's disease.EOP, a newly synthesized ethyl pyruvate derivative, attenuates the production of inflammatory mediators via p38, ERK and NF-κB pathways in lipopolysaccharide-activated BV-2 microglial cells.Molecular pathology of cerebral TNF-α, IL-1β, iNOS and Nrf2 in forensic autopsy cases with special regard to deaths due to environmental hazards and intoxication.Isoorientin attenuates lipopolysaccharide-induced pro-inflammatory responses through down-regulation of ROS-related MAPK/NF-κB signaling pathway in BV-2 microglia.The PPARgamma agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B.PPARs in Alzheimer's Disease.Transcriptional regulation of murine Slc22a1 (Oct1) by peroxisome proliferator agonist receptor-alpha and -gamma.Impact and Therapeutic Potential of PPARs in Alzheimer's Disease.PPARs in Irradiation-Induced Gastrointestinal Toxicity.PPARs: a new target for neuroprotection.Essential fatty acid-rich diets protect against striatal oxidative damage induced by quinolinic acid in rats.Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms.Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.Ghrelin improves pilocarpine‑induced cerebral cortex inflammation in epileptic rats by inhibiting NF‑κB and TNF‑α
P2860
Q21342822-F9B6A7A1-3B02-47C9-B69E-C054632536DCQ28075617-FE9A3450-A673-4AA4-BED7-97ADC8EDDC3CQ28079731-DF529906-B851-462B-843C-BDBA80045CB1Q30391351-C8877794-F4E9-4D30-830B-AE6ED32D601FQ33575523-D94A050C-2EBC-4598-AA23-39856BFD8259Q34203838-1547A14D-2419-49A6-B825-DEE8DADF1225Q35015002-9E8FADE1-E8CC-492C-BBFF-243861B0F50AQ35176258-ECC39E56-0BAB-4254-9878-19DE18CD8909Q35196195-C67BF859-34B7-4B24-88A9-59E889B04CCDQ36100305-38E5F23F-BEF3-43B6-BF90-6CEE4976ACF9Q36298203-D56EAEDB-2F88-47BC-A1B2-5C1E4032BBDFQ36478649-369E70BB-62F9-429A-9DE6-D19E80F27BECQ36591722-76C9FE44-4262-4F69-A4DB-FCBE5C798444Q36939320-89E7FE8E-B7D6-4EE0-8807-98D7C0F726E9Q37104674-82EF7B6E-4CEF-4A1E-A8DE-E1F77E98D0D9Q37157531-5F68B2AC-80BB-4775-8156-9777C222FE8FQ37211800-8B4A9885-5091-479D-B709-E6713CCC8E38Q37291297-000A2F3C-90BB-47E8-8AD2-AD768B648CB1Q37397863-42DE8447-D454-4D4D-8542-5286D23800B1Q37878981-2DFEA7E0-4896-4D56-BFFF-31D5F5EF7C98Q38032481-D8C098FB-3186-47CD-AD4C-23CE0CC2852CQ38864839-036E6736-E9E8-4766-9957-0D6F3BB86854Q38937361-6E4983A0-404E-48E7-85FC-FDE39D0A223BQ38978481-55CF8C3D-7A91-4A10-A0A9-3CAE08504E83Q39082239-66BDA424-D59F-4125-B2F4-17397795798CQ39542236-032EED6A-1F85-43C6-B2E3-86F21BB8C835Q40288794-9E184544-9790-430A-A8C9-2422EB638F4BQ40508991-0D2586CA-8171-4F0E-B07A-3E27BFE6FFC1Q40576825-E608E675-F858-4FF0-9372-2064F03104E2Q41972470-E56B5CC5-F976-412A-B668-434177DDD0A8Q42718625-351D6341-8CA4-4669-9A2E-A9186D5AF26AQ45293662-64DF9504-CF8C-4148-85DC-AA72B9410736Q46293996-B6896427-1FD8-4601-A5C3-2394F64B9D03Q46611073-AEBD4013-BB21-4483-BB9B-AC3D34112A4CQ50306200-96F0A09F-CCEE-48C0-96A9-A972FA8731FBQ58789174-F2E5C0AF-3E1D-402B-B8C5-44C948454B41
P2860
Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Effects of peroxisome prolifer ...... ssociated with iNOS and COX-2.
@en
type
label
Effects of peroxisome prolifer ...... ssociated with iNOS and COX-2.
@en
prefLabel
Effects of peroxisome prolifer ...... ssociated with iNOS and COX-2.
@en
P2093
P1433
P1476
Effects of peroxisome prolifer ...... ssociated with iNOS and COX-2.
@en
P2093
Chang Hyun Moon
Eun Joo Baik
Eun Joo Kim
Jee Young Park
Kyoung Ja Kwon
Soo Hwan Lee
P356
10.1016/S0006-8993(02)02480-0
P407
P577
2002-06-01T00:00:00Z